Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 178
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can low carbohydrate ketogenic diets inhibit cancers?

    Insulin is a hormone which supports growth of normal cells, but also of cancers. A very low carbohydrate (VLC...

    What can we do to improve survival in babies with respiratory distress in Bangladesh?

    Respiratory Distress is a treatable disease which kills hundreds of thousands of babies every year. Most of...

    Detection of Zika virus rapidly without the need for a laboratory in Brazil

    Zika (PORTUGUESE) is a rapidly emerging pandemic, a global health emergency. ZIKV has been associated with central...

    Backer Badge Funded